£1 million study could identify a new form of genetic diabetes
A cash injection of nearly £1 million will help researchers unravel the genetics mysteries of a rare form of diabetes, which might lead to identifying a new form of the condition. ...
A cash injection of nearly £1 million will help researchers unravel the genetics mysteries of a rare form of diabetes, which might lead to identifying a new form of the condition. ...
Diabetes teams are gearing up to take part in Insulin Safety Week (ISW) 2020 which kicks off next month. Originally, the annual campaign was scheduled to take place in May 2020, but due to the ...
Four top key opinion leaders are coming together to decipher the main outcomes from the American Diabetes Association (ADA) Scientific Conference. Dr Kevin Fernando, Nurse Consultant Debbie ...
Trusts and commissioners are being urged to “adopt a system-wide approach” to ensure good practice is carried out during the transition phase from children’s and adults’ services. A national ...
COVID-19 might be triggering diabetes in previously healthy people, a team of international experts has warned. New cases of the blood sugar condition have been repeatedly diagnosed in people who ...
Healthcare professionals and people with diabetes are being reminded that taking the steroid treatment dexamethasone could impact blood glucose levels significantly. It has been recognised that ...
Diabetes nurses across Europe are being asked to take part in a survey to help gain perspective on the impact of COVID-19 within their work. The anonymous survey, which only takes 15 minutes to ...
Input is being sought to help areas of research which will improve the healthcare and wellbeing of women and families affected by diabetes in pregnancy. The University of Oxford, James Lind ...
Research drives improvements to frontline healthcare. The evidence it generates is at the core of medical innovations, pathways and treatments. Our Behind the Science feature tackles the latest ...
A “staggering and much needed saving” of £298m could be made to the NHS if a specific type 2 diabetes drug was given to people at risk of cardiovascular death or heart failure. That’s ...